Uniseed logo

Uniseed

Oceania, Queensland, Australia, Brisbane

Description

Seeding Technology Ventures

Investor Profile

Uniseed has made 15 investments, with 2 in the past 12 months and 13% as lead.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Series C (13%)
  • Seed (7%)
  • Series Unknown (7%)
  • Angel (7%)

Country Focus

  • Australia (80%)
  • United Kingdom (13%)
  • United States (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Biopharma
  • Electronics
  • Manufacturing
  • Software
  • Pharmaceutical
  • Medical
  • Mobile
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Uniseed frequently co-invest with?

UNSW Founders
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
UniQuest
Oceania, Queensland, Australia, Brisbane
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
UniSuper
Oceania, Victoria, Australia, Melbourne
Co-Investments: 2
GBS Ventures
Oceania, Victoria, Australia, Melbourne
Co-Investments: 3
Brandon Capital
Oceania, Victoria, Australia, Melbourne
Co-Investments: 3
Stoic VC
Oceania, New South Wales, Australia, Sydney
Co-Investments: 3
Southern Cross Venture Partners
Oceania, New South Wales, Australia, North Sydney
Co-Investments: 2
Atlas Advisors
North America, New York, United States, New York
Co-Investments: 1

Which angels does Uniseed often collaborate with?

RT
North America, Pennsylvania, United States
Shared Deals: 1

What are some of recent deals done by Uniseed?

Celosia Therapeutics

Sydney, New South Wales, Australia

A biotechnology company that uses gene therapy to treat neurodegenerative diseases.

BiopharmaBiotechnology
Series ANov 27, 2024
Amount Raised: $16,750,000
Kinoxis Therapeutics

Melbourne, Victoria, Australia

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

BiotechnologyTherapeutics
Series BAug 12, 2024
Amount Raised: $9,548,268
Aravax

Melbourne, Victoria, Australia

Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.

BiotechnologyHealth CareWellness
Series BJan 23, 2024
Amount Raised: $22,200,000
Ferronova

Adelaide, South Australia, Australia

Ferronova is a medical device company that offers imaging and surgery products.

BiotechnologyClinical TrialsHealth CareMedical Device
Series BJan 22, 2023
Amount Raised: $5,586,889
Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series UnknownJun 17, 2021
Amount Raised: $24,181,549
Ena Respiratory

Melbourne, Victoria, Australia

Ena Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.

BiotechnologyHealth DiagnosticsMedical
Series ASep 28, 2020
Amount Raised: $8,299,573
Forcite Helmet Systems

Sydney, New South Wales, Australia

ARAS systems for Motoryclists

ElectronicsManufacturingMobileProduct DesignSoftware
SeedFeb 25, 2019
Amount Raised: $950,000
Brisbane Materials Technology

Darra, Queensland, Australia

Brisbane Materials aims to be the leading supplier of anti-reflective and anti-soiling coatings for solar and other applications.

EnergyInformation TechnologyRenewable EnergySolar
Series BJun 18, 2017
Exonate

Cambridge, Cambridgeshire, United Kingdom

Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsPharmaceutical
AngelNov 30, 2016
Amount Raised: $1,876,799
Spinifex Pharmaceuticals

Preston, Lancashire, United Kingdom

Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.

BiotechnologyHealth CarePharmaceutical
Series CApr 10, 2014
Amount Raised: $45,000,000